SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-011761
Filing Date
2024-03-28
Accepted
2024-03-28 16:30:41
Documents
15
Period of Report
2024-03-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42795
2 ex10-1.htm EX-10.1 32973
3 ex10-2.htm EX-10.2 43471
  Complete submission text file 0001493152-24-011761.txt   311312

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE nrxs-20240322.xsd EX-101.SCH 3015
5 XBRL LABEL FILE nrxs-20240322_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE nrxs-20240322_pre.xml EX-101.PRE 22359
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3758
Mailing Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032
Business Address 11611 N. MERIDIAN ST SUITE 330 CARMEL IN 46032 (812) 689-0791
Neuraxis, INC (Filer) CIK: 0001933567 (see all company filings)

IRS No.: 455079684 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41775 | Film No.: 24799579
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 03 Life Sciences)